Savings Effect

FROM BLOOMBERG FIIS expect the Indian rupee to weaken further, with some even gaming out scenarios where the currency falls to an unprecedented 100 per dollar

GOLD JEWELLERY ASSOCIATION SAYS WE ARE SEEING DISTRESS AS DEMAND DROPS|| BUYERS HAVE DIPPED IN LAST 10 DAYS: CNBC AWAAZ

BPCL: CO SAYS DO NOT FORESEE ANY STRESS ON BALANCE SHEET FOR FY27 - CONCALL UPDATE

BSE & #NSE approve merger of #HindujaLeylandFinance with co, says #NDLVentures

Indonesian govt considering setting up a govt agency to manage raw material exports, looks to increase global prices of raw materials like #palmoil & coal: From bloomberg Alert: Indonesia accounts for more than half of global palm oil exports Indonesia President is expected to announce 2027 budget framework today

HEMANT SURGICAL INDUSTRIES: CO ALLOTS 6,49,600 EQUITY SHARES OR 5% STAKE CONSEQUENT TO CONVERSION OF CONVERTIBLE WARRANTS TO SINGULARITY EQUITY FUND 1 (MADHUSUDAN KELA) || NOW SHAREHOLDING STANDS AT 6.9% IN CO. - SME

HEMANT SURGICAL INDUSTRIES: CO ALLOTS 6,49,600 EQUITY SHARES OR 5% STAKE CONSEQUENT TO CONVERSION OF CONVERTIBLE WARRANTS TO SINGULARITY EQUITY FUND 1 (MADHUSUDAN KELA) || NOW SHAREHOLDING STANDS AT 6.9% IN CO.

ZydusLife surges over 5% in a weak market, here are the concall updates Mgmt guides for us rev base of over $300 m/qtr with single-digit FY27 growth. US revenues estimated at $1.3–1.4 bn in FY27 , India business expected to grow, aided by oncology & GLP-1 portfolio International business guided to grow 40–45% in FY27

Genus Power: Guidance - - Concall Update Management expects FY '27 revenue between INR6,000 crore and INR6,500 crore, driven by increased rollout intensity and conversion of the order book. For FY '27, the EBITDA margin guidance is 18%, a reduction of 2% to 2.5% from FY '26, due to anticipated surges in raw material prices from war, petroleum, and chip costs. No major CapEx is planned for FY '27, only regular CapEx of INR10 crores to INR20 crores for items like dies and molds. Working capital days are expected to improve by another 50 to 75 days in the current year, following a reduction from 343 days in March '25 to 274 days in March '26. The company expects net debt to peak at approximately INR1,900 crores to INR2,000 crores, up from INR1,573 crore as of March '26, with reductions starting from FY '28 onwards. Cash flow from operations is expected to be at par or slightly negative by the end of FY '27, with positive cash flow projected for the first or second quarter of FY '28. The company plans to invest another INR600 crores to INR700 crores in the joint venture platform with GIC over the next two years (FY '27 and FY '28) and Q1 FY '29. For FY '27, the company aims to install more than 1 crore meters. The company targets INR500 crores in export revenue within the next two to three years, expecting meaningful numbers by the end of FY '27. O&M revenue from the current order book is projected to reach INR800 crores to INR900 crores per annum in the next two to three years, up from INR150 crores in FY '26.

Afcons Infra: Guidance - - Concall Update Management is not providing specific revenue growth or EBITDA margin guidance for FY27 due to continued geopolitical uncertainty, elongated award cycles, and ongoing project developments. The order booking guidance for FY27 is INR30,000 crores, with INR15,000 crores having clear visibility, including L1 orders, and the remaining INR15,000 crores also having definitive visibility. The CapEx for FY27 is projected to be around INR725 crores. Management expects a sizable drop in debt for FY27 and aims to reduce working capital days to around 120, with approximately INR1,000 crores of receivables expected to be unlocked by June.

GPT Healthcare: Guidance - - Concall Update For FY '27, GPT Healthcare expects overall revenue to increase by 15% year-over-year, with EBITDA margin growing by approximately 100 basis points to around 20.2%. The company anticipates ARPOB to grow by approximately 8% in FY '27 due to tariff increases and specialty optimization, with Agartala's ARPOB increasing by 7% to 8% but remaining lower than Kolkata units. The Raipur Hospital is projected to reach a monthly operational breakeven by Q3 FY '27, closing the year at around 30% occupancy, with a slight full-year loss before becoming fully positive next year. Jamshedpur Hospital, a 150-bed facility, is expected to be commissioned by Q4 FY '27 with a CapEx of approximately INR 70 lakhs per bed, following a similar ramp-up trend as Raipur. Occupancy targets for FY '27 include Salt Lake at 70-73%, Dum Dum at 72-78%, Agartala moving towards 58%, and Howrah reaching the late 50s.

APOLLO TYRES: CO PLANS RS. 3,500 CR EXPANSION AMID RISING RUBBER COSTS || CO CEO SAYS ADDED THAT MAJORITY OF THE CAPEX NEARLY 80% WILL BE USED TOWARDS GROWTH AND CAPACITY EXPANSION PROJECTS WITH CLOSE TO ₹3,000 CRORE TO BE SPENT IN INDIA AND THE BALANCE IN EUROPE. - BL

GNFC: Guidance -- Concall Update Management expects to finalize new project identification for investment decisions by the end of the current calendar year. The CapEx for FY27 is projected to be around INR 2,800 crores, with details for FY28 to be provided in subsequent quarters. The coal-based CCPP is expected to synchronize by the third week of June and be fully operational by the third week of August 2026, with an estimated saving potential of INR 10-12 crore per month accruing from H2 FY27. Ammonia expansion, weak nitric acid, and ammonium nitrate melt plants are all expected to come online by next year (FY27), though weak nitric acid has a minor delay of approximately 2.5 months. Management does not foresee the fertilizer segment, specifically urea, turning positive until fixed cost and energy norms are revised, as losses are currently widening.

CDSCO CRACKS DOWN ON SURROGATE ADVERTISING OF GLP-1 WEIGHT-LOSS DRUGS ACROSS DIGITAL, PRINT, TV, SOCIAL MEDIA AND OUTDOOR PLATFORMS. - BS

RBI LIKELY TO HOLD REPO RATE AT 5.25% THROUGH FY27: INDIA RATINGS

STAR HEALTH AND ALLIED INSURANCE: CO AIMS TO DERIVE 65% OF ITS BUSINESS FROM SMALLER CITIES WHILE TARGETING ₹24,000 CRORE PREMIUM IN FY27 AND LAUNCHING ITS NEW ‘VALUE PLUS’ HEALTH INSURANCE PRODUCT. - BS

INDIA’S PROPOSED ₹1.5 TRILLION INDIA SEMICONDUCTOR MISSION 2.0 MAY EXTEND THE SCHEME TENURE TO 12 YEARS WITH SHARPER INCENTIVES FOR INTEGRATED SEMICONDUCTOR UNITS AND SUPPLIERS OF GASES, INGOTS, AND OTHER CHIPMAKING RAW MATERIALS. - BS